Difference between revisions of "Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5 (Q9901)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 29863979, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Publication Date (P100): 2018, #quickstatements; #temporary_batch_1590002823654) |
||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2018
| ||||||||||||||
| Property / Publication Date: 2018 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Revision as of 19:50, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Migden MR
0 references
2018
0 references
